Manulife (Manufacturers Life Insurance)
CATX icon

Manulife (Manufacturers Life Insurance)’s Perspective Therapeutics CATX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.6K Sell
16,681
-2,350
-12% -$9.93K ﹤0.01% 2688
2025
Q4 		$52.3K Sell
19,031
-2,245
-11% -$6.41K ﹤0.01% 2812
2025
Q3 		$73K Sell
21,276
-276
-1% -$1.01K ﹤0.01% 2835
2025
Q2 		$74.1K Buy
21,552
+1,414
+7% +$3.73K ﹤0.01% 2824
2025
Q1 		$42.9K Sell
20,138
-22
-0.1% -$66 ﹤0.01% 2848
2024
Q4 		$64.3K Sell
20,160
-354
-2% -$2.89K ﹤0.01% 2901
2024
Q3 		$274K Buy
20,514
+1,672
+9% +$22.2K ﹤0.01% 2517
2024
Q2 		$188K Buy
+18,842
New +$272K ﹤0.01% 2629

Other funds holding CATX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CATX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Perspective Therapeutics (CATX) stake by 12% in Q1 2026, selling an estimated $9.93K and leaving 16,681 shares worth $69.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2688.

Manulife (Manufacturers Life Insurance) first reported a position in CATX in Q2 2024 and has held it in 8 quarters since. The position peaked at $274K in Q3 2024. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 16,681 shares of Perspective Therapeutics worth $69.6K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 2,350 Perspective Therapeutics shares in Q1 2026, an estimated $9.93K.
  • Perspective Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2688 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Perspective Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Perspective Therapeutics position peaked at $274K in Q3 2024.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.